The FDA issued its first stamp of approval for a cell or gene therapy back in 2017 to Novartis' Kymriah. | The gene therapy ...
In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback